Before the treatment, 82% of participants reported ODI scores that placed them in the “severe” or “crippled” category. By 12 months, that number had dropped to 18%.

Some experts say involuntary addiction treatment raises serious ethical concerns and could even increase the risk of overdose for some, as Ontario weighs whether it could mandate treatment for ...

NEWS NINE. THE TOWN OF MILFORD MAKING UPGRADES TO ITS WASTEWATER TREATMENT PLANT TO HELP REDUCE THE LEVEL OF CHEMICALS AND METAL IN WATER THAT GOES INTO THE SOUHEGAN RIVER. THAT WATER THEN GOES ...

The vagus nerve runs from the brain to the large intestine, and controls involuntary functions including digestion and your mood This new treatment works in tandem with a traditional PTSD ...

Instead, KJ has made medical history. The baby, now 9 ½ months old, became the first patient of any age to have a custom gene-editing treatment, according to his doctors. He received an infusion ...

TREATMENT HAS ALREADY CHANGED MILLIONS OF LIVES IN THIS BUILDING. ONE DOCTOR DISCOVERED A BREAKTHROUGH THAT IS CHANGING THE LIVES OF PEOPLE LIVING WITH MULTIPLE SCLEROSIS. THESE PATIENTS, WITH ...

Regular urine protein tests every 6-12 months to detect kidney involvement A kidney biopsy may be needed if urine and blood test indicate kidney involvement to guide treatment. Interested in getting ...

Following report of a patient’s death after treatment with Sarepta’s Duchenne muscular dystrophy gene therapy Elevidys, some families have paused the treatment process to seek additional ...

Emma Dimery, diagnosed with Stage 4 colon cancer in 2013, has recovered. After nearly a decade of treatments, she enrolled in a clinical trial in 2022. The trial at the University of Minnesota ...

"I had been waiting for a clinical trial," recalled Dimery, now 35. "I had exhausted every other standard of treatment, and even some not-so-standard ones." When Dimery heard about a new trial at ...

Atzumi is the first dihydroergotamine-based nasal powder approved for migraine treatment in adults. Approval was based on favorable safety, efficacy and tolerability data from two clinical trials.

The findings, recently published in eBioMedicine, may help inform clinical trials of a drug that is already approved by the U.S. Food and Drug Administration for psoriasis as a treatment for Type ...